Anti-microtubule binding region-tau antibody being investigated as a potential disease-modifying therapy to slow or delay progression of disease
Panacea Biotec receives Rs. 315 crore LoA from UNICEF
With global certification in place, the Ambernath site expands Supriya’s footprint beyond APIs into high-margin formulations
Proposed acquisition adds petosemtamab, a late-stage asset with two Breakthrough Therapy Designations, to Genmab’s portfolio
Pfizer will participate in TrumpRx.gov, a direct-to-patient purchasing platform offering discount up to 85%
Hyperion results presented at ERS 2025 and simultaneously published in the New England Journal of Medicine
Brenntag will showcase forward-looking formulations designed to respond to Indonesia’s evolving beauty and self-care needs
FDA authorization was based on two years of clinical study data demonstrating that Essilor Stellest lenses significantly slowed myopia progression compared to single-vision control lenses
Sanofi Ventures drives innovation through leading and participating in private financing rounds for pioneering healthcare companies
Health leaders rally for a national awakening on prevention, mental wellness, and lifestyle reform at ‘Illness to Wellness’ heart care conference
Subscribe To Our Newsletter & Stay Updated
